Next Article in Journal
Predictive Modeling of Factors Influencing Adherence to SGLT-2 Inhibitors in Ambulatory Care: Insights from Prescription Claims Data Analysis
Previous Article in Journal
Co-Administration of Influenza and COVID-19 Vaccines: A Cross-Sectional Survey of Canadian Adults’ Knowledge, Attitudes, and Beliefs
Previous Article in Special Issue
Charting the Knowledge and Patterns of Non-Steroidal Anti-Inflammatory Drugs Usage in Hail Population, Saudi Arabia: Insights into the Adverse Effect Profile
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Redesigning Medication Management in the Emergency Department: The Impact of Partnered Pharmacist Medication Charting on the Time to Administer Pre-Admission Time-Critical Medicines, Medication Order Completeness, and Venous Thromboembolism Risk Assessment

1
School of Pharmacy and Pharmacology, College of Health and Medicine, University of Tasmania, Hobart 7005, Australia
2
Pharmacy Department, Royal Hobart Hospital, Tasmanian Health Service, Hobart 7000, Australia
3
Marinova Pty Ltd., Cambridge 7170, Australia
*
Author to whom correspondence should be addressed.
Pharmacy 2024, 12(2), 71; https://doi.org/10.3390/pharmacy12020071
Submission received: 18 March 2024 / Revised: 8 April 2024 / Accepted: 16 April 2024 / Published: 17 April 2024

Abstract

In order to enhance interdisciplinary collaboration and promote better medication management, a partnered pharmacist medication charting (PPMC) model was piloted in the emergency department (ED) of an Australian referral hospital. The primary objective of this study was to evaluate the impact of PPMC on the timeliness of time-critical medicines (TCMs), completeness of medication orders, and assessment of venous thromboembolism (VTE) risk. This concurrent controlled retrospective pragmatic trial involved individuals aged 18 years and older presenting to the ED from 1 June 2020 to 17 May 2021. The study compared the PPMC approach (PPMC group) with traditional medical officer-led medication charting approaches in the ED, either an early best-possible medication history (BPMH) group or the usual care group. In the PPMC group, a BPMH was documented promptly soon after arrival in the ED, subsequent to which a collaborative discussion, co-planning, and co-charting of medications were undertaken by both a PPMC-credentialled pharmacist and a medical officer. In the early BPMH group, the BPMH was initially obtained in the ED before proceeding with the traditional approach of medication charting. Conversely, in the usual care group, the BPMH was obtained in the inpatient ward subsequent to the traditional approach of medication charting. Three outcome measures were assessed –the duration from ED presentation to the TCM’s first dose administration (e.g., anti-Parkinson’s drugs, hypoglycaemics and anti-coagulants), the completeness of medication orders, and the conduct of VTE risk assessments. The analysis included 321 TCMs, with 107 per group, and 1048 patients, with 230, 230, and 588 in the PPMC, early BPMH, and usual care groups, respectively. In the PPMC group, the median time from ED presentation to the TCM’s first dose administration was 8.8 h (interquartile range: 6.3 to 16.3), compared to 17.5 h (interquartile range: 7.8 to 22.9) in the early BPMH group and 15.1 h (interquartile range: 8.2 to 21.1) in the usual care group (p < 0.001). Additionally, PPMC was associated with a higher proportion of patients having complete medication orders and receiving VTE risk assessments in the ED (both p < 0.001). The implementation of the PPMC model not only expedited the administration of TCMs but also improved the completeness of medication orders and the conduct of VTE risk assessments in the ED.
Keywords: partnered pharmacist; interdisciplinary; co-charting; medication charting; emergency department; time-critical medicine; medication order; venous thromboembolism partnered pharmacist; interdisciplinary; co-charting; medication charting; emergency department; time-critical medicine; medication order; venous thromboembolism

Share and Cite

MDPI and ACS Style

Atey, T.M.; Peterson, G.M.; Salahudeen, M.S.; Simpson, T.; Boland, C.M.; Anderson, E.; Wimmer, B.C. Redesigning Medication Management in the Emergency Department: The Impact of Partnered Pharmacist Medication Charting on the Time to Administer Pre-Admission Time-Critical Medicines, Medication Order Completeness, and Venous Thromboembolism Risk Assessment. Pharmacy 2024, 12, 71. https://doi.org/10.3390/pharmacy12020071

AMA Style

Atey TM, Peterson GM, Salahudeen MS, Simpson T, Boland CM, Anderson E, Wimmer BC. Redesigning Medication Management in the Emergency Department: The Impact of Partnered Pharmacist Medication Charting on the Time to Administer Pre-Admission Time-Critical Medicines, Medication Order Completeness, and Venous Thromboembolism Risk Assessment. Pharmacy. 2024; 12(2):71. https://doi.org/10.3390/pharmacy12020071

Chicago/Turabian Style

Atey, Tesfay Mehari, Gregory M. Peterson, Mohammed S. Salahudeen, Tom Simpson, Camille M. Boland, Ed Anderson, and Barbara C. Wimmer. 2024. "Redesigning Medication Management in the Emergency Department: The Impact of Partnered Pharmacist Medication Charting on the Time to Administer Pre-Admission Time-Critical Medicines, Medication Order Completeness, and Venous Thromboembolism Risk Assessment" Pharmacy 12, no. 2: 71. https://doi.org/10.3390/pharmacy12020071

APA Style

Atey, T. M., Peterson, G. M., Salahudeen, M. S., Simpson, T., Boland, C. M., Anderson, E., & Wimmer, B. C. (2024). Redesigning Medication Management in the Emergency Department: The Impact of Partnered Pharmacist Medication Charting on the Time to Administer Pre-Admission Time-Critical Medicines, Medication Order Completeness, and Venous Thromboembolism Risk Assessment. Pharmacy, 12(2), 71. https://doi.org/10.3390/pharmacy12020071

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop